Genetic mechanisms and age-related macular degeneration: common variants, rare variants, copy number variations, epigenetics, and mitochondrial genetics.

PubWeight™: 0.90‹?›

🔗 View Article (PMC 3500238)

Published in Hum Genomics on August 31, 2012

Authors

Melissa M Liu1, Chi-Chao Chan, Jingsheng Tuo

Author Affiliations

1: Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892-1857, USA.

Articles citing this

Environmental Epigenetics and a Unified Theory of the Molecular Aspects of Evolution: A Neo-Lamarckian Concept that Facilitates Neo-Darwinian Evolution. Genome Biol Evol (2015) 0.97

Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects. Clin Ophthalmol (2015) 0.91

Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks. Mediators Inflamm (2013) 0.91

Rat retinal transcriptome: effects of aging and AMD-like retinopathy. Cell Cycle (2013) 0.91

Review: Epigenetic mechanisms in ocular disease. Mol Vis (2013) 0.91

Vision from next generation sequencing: multi-dimensional genome-wide analysis for producing gene regulatory networks underlying retinal development, aging and disease. Prog Retin Eye Res (2015) 0.90

Beta-Amyloid Precursor Protein (βAPP) Processing in Alzheimer's Disease (AD) and Age-Related Macular Degeneration (AMD). Mol Neurobiol (2014) 0.87

Mitochondrial DNA variants can mediate methylation status of inflammation, angiogenesis and signaling genes. Hum Mol Genet (2015) 0.85

Genetic architecture of retinal and macular degenerative diseases: the promise and challenges of next-generation sequencing. Genome Med (2013) 0.83

Functional and structural brain modifications induced by oculomotor training in patients with age-related macular degeneration. Front Psychol (2013) 0.82

The role of epigenetics in age-related macular degeneration. Eye (Lond) (2014) 0.81

Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration. Cell Mol Life Sci (2014) 0.80

Epimacular brachytherapy for wet AMD: current perspectives. Clin Ophthalmol (2014) 0.80

Stem cells as tools for studying the genetics of inherited retinal degenerations. Cold Spring Harb Perspect Med (2014) 0.77

Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and Apoptosis. PLoS One (2015) 0.77

GSTM1 and GSTM5 Genetic Polymorphisms and Expression in Age-Related Macular Degeneration. Curr Eye Res (2015) 0.76

Highly penetrant alleles in age-related macular degeneration. Cold Spring Harb Perspect Med (2014) 0.75

Single Nucleotide Polymorphisms of the Sirtuin 1 (SIRT1) Gene are Associated With age-Related Macular Degeneration in Chinese Han Individuals: A Case-Control Pilot Study. Medicine (Baltimore) (2015) 0.75

Articles cited by this

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell (2005) 96.87

Complement factor H polymorphism in age-related macular degeneration. Science (2005) 31.10

Origins and functional impact of copy number variation in the human genome. Nature (2009) 23.63

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol (2001) 21.37

MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol (2005) 18.94

Complement factor H variant increases the risk of age-related macular degeneration. Science (2005) 17.95

Complement factor H polymorphism and age-related macular degeneration. Science (2005) 17.79

DNA methylation and human disease. Nat Rev Genet (2005) 12.00

Environmental epigenomics and disease susceptibility. Nat Rev Genet (2007) 11.02

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol (1995) 10.61

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet (2000) 8.58

An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res (2001) 8.38

The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol (2000) 8.10

Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet (2007) 8.07

Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol (2010) 7.75

Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet (2009) 7.64

Genomic disorders: molecular mechanisms for rearrangements and conveyed phenotypes. PLoS Genet (2005) 7.60

HTRA1 promoter polymorphism in wet age-related macular degeneration. Science (2006) 7.12

Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov (2010) 6.07

Mechanisms for human genomic rearrangements. Pathogenetics (2008) 4.54

Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. N Engl J Med (2008) 4.46

Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A (2010) 4.30

Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat Genet (2008) 4.16

A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet (2006) 3.96

Decline in genomic DNA methylation through aging in a cohort of elderly subjects. Mech Ageing Dev (2008) 3.93

DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature (2011) 3.90

A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat Genet (2011) 3.55

Molecular pathology of age-related macular degeneration. Prog Retin Eye Res (2008) 3.35

Age-related macular degeneration. Lancet (2008) 3.34

Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A (2010) 3.33

Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study. Lancet (2008) 3.21

Missense variations in the fibulin 5 gene and age-related macular degeneration. N Engl J Med (2004) 3.15

Age-related macular degeneration--emerging pathogenetic and therapeutic concepts. Ann Med (2006) 2.99

Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol (2011) 2.89

Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. Hum Mol Genet (2003) 2.72

Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann Med (2006) 2.65

Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp Eye Res (2003) 2.51

Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum Mol Genet (2005) 2.32

Histopathology of age-related macular degeneration. Mol Vis (1999) 2.27

Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23~27~24 clusters. Proc Natl Acad Sci U S A (2011) 2.10

Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. Am J Ophthalmol (2000) 2.07

The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J (2004) 2.04

Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet (2011) 1.98

Mitochondrial DNA damage and its potential role in retinal degeneration. Prog Retin Eye Res (2008) 1.96

An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). Hum Mol Genet (2010) 1.95

Mitochondrial DNA haplogroups and age-related maculopathy. Arch Ophthalmol (2007) 1.90

MicroRNAs regulate ocular neovascularization. Mol Ther (2008) 1.89

Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration. Hum Mol Genet (2007) 1.83

Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits. Hum Mol Genet (2007) 1.82

Smoking, dietary betaine, methionine, and vitamin D in monozygotic twins with discordant macular degeneration: epigenetic implications. Ophthalmology (2011) 1.81

Glutathione transferases in the genomics era: new insights and perspectives. Biomol Eng (2006) 1.60

Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition. Proc Natl Acad Sci U S A (2006) 1.52

Gene copy number variation and common human disease. Clin Genet (2009) 1.46

Association assessment of copy number polymorphism and risk of age-related macular degeneration. Ophthalmology (2011) 1.46

Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population. Nat Genet (2011) 1.43

Possible gene dosage effect of glutathione-S-transferases on atopic asthma: using real-time PCR for quantification of GSTM1 and GSTT1 gene copy numbers. Hum Mutat (2004) 1.37

Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD). Int J Biochem Mol Biol (2012) 1.37

The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest Ophthalmol Vis Sci (2004) 1.34

Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration. Histol Histopathol (2005) 1.32

Increased mitochondrial DNA damage and down-regulation of DNA repair enzymes in aged rodent retinal pigment epithelium and choroid. Mol Vis (2008) 1.31

ARMS2 is a constituent of the extracellular matrix providing a link between familial and sporadic age-related macular degenerations. Invest Ophthalmol Vis Sci (2009) 1.30

Alleles in the HtrA serine peptidase 1 gene alter the risk of neovascular age-related macular degeneration. Ophthalmology (2007) 1.30

Mitochondrial DNA damage as a potential mechanism for age-related macular degeneration. Invest Ophthalmol Vis Sci (2010) 1.28

Mitochondrial DNA haplogroups associated with age-related macular degeneration. Invest Ophthalmol Vis Sci (2009) 1.26

Mitochondrial abnormalities in ageing macular photoreceptors. Invest Ophthalmol Vis Sci (2001) 1.25

Mitochondrial DNA polymorphism A4917G is independently associated with age-related macular degeneration. PLoS One (2008) 1.23

The role of complement in AMD. Adv Exp Med Biol (2010) 1.21

Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degeneration. PLoS One (2009) 1.19

Mitochondrial DNA repair and association with aging--an update. Exp Gerontol (2010) 1.19

Genome-wide association study of age-related macular degeneration identifies associated variants in the TNXB-FKBPL-NOTCH4 region of chromosome 6p21.3. Hum Mol Genet (2012) 1.18

The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples. Invest Ophthalmol Vis Sci (2007) 1.17

Genetics of age-related macular degeneration: current concepts, future directions. Semin Ophthalmol (2011) 1.16

Genome-wide association identifies SKIV2L and MYRIP as protective factors for age-related macular degeneration. Genes Immun (2010) 1.16

The molecular genetic basis of age-related macular degeneration: an overview. J Genet (2009) 1.15

Contribution of copy number variation in the regulation of complement activation locus to development of age-related macular degeneration. Invest Ophthalmol Vis Sci (2009) 1.07

A 32 kb critical region excluding Y402H in CFH mediates risk for age-related macular degeneration. PLoS One (2011) 1.05

Analysis of the Y402H variant of the complement factor H gene in age-related macular degeneration. Invest Ophthalmol Vis Sci (2006) 1.03

Age-related macular degeneration: a perspective on genetic studies. Eye (Lond) (2007) 1.00

Genetic profile for five common variants associated with age-related macular degeneration in densely affected families: a novel analytic approach. Eur J Hum Genet (2009) 1.00

Copy number variants in genetic susceptibility and severity of systemic lupus erythematosus. Cytogenet Genome Res (2009) 0.98

Effect of miR-23 on oxidant-induced injury in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (2011) 0.96

The association between copy number variations in glutathione S-transferase M1 and T1 and age-related cataract in a Han Chinese population. Invest Ophthalmol Vis Sci (2010) 0.96

Copy number variations in candidate genes in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 0.95

Copy-number variation genotyping of GSTT1 and GSTM1 gene deletions by real-time PCR. Clin Chem (2009) 0.94

Genome-wide analysis of copy number variants in age-related macular degeneration. Hum Genet (2010) 0.91

CCL3L1 copy number variation and susceptibility to HIV-1 infection: a meta-analysis. PLoS One (2010) 0.90

Glutathione S-transferase M1, T1, and P1 gene polymorphism in exudative age-related macular degeneration: a preliminary report. Eur J Ophthalmol (2006) 0.90

miRNAs as potential therapeutic targets for age-related macular degeneration. Future Med Chem (2012) 0.87

Nutritional supplementation and age-related macular degeneration. Semin Ophthalmol (2011) 0.86

Characterization of retinal and blood mitochondrial DNA from age-related macular degeneration patients. Invest Ophthalmol Vis Sci (2010) 0.86

Glutathione S-transferase M1, GSTT1 and GSTP1 genetic polymorphisms and the risk of age-related macular degeneration. Ophthalmic Res (2011) 0.84

DNA damage and repair in age-related macular degeneration. Front Biosci (Landmark Ed) (2011) 0.78

Articles by these authors

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J Immunol (2005) 6.95

Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood (2008) 6.81

Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med (2008) 5.25

The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. Invest Ophthalmol Vis Sci (2012) 4.11

Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81

Rapamycin slows aging in mice. Aging Cell (2012) 3.76

Molecular pathology of age-related macular degeneration. Prog Retin Eye Res (2008) 3.35

Age-related macular degeneration. Lancet (2008) 3.34

Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity (2011) 2.64

Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Invest Ophthalmol Vis Sci (2007) 2.36

Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye. Invest Ophthalmol Vis Sci (2002) 2.19

Genetic factors of age-related macular degeneration. Prog Retin Eye Res (2004) 2.17

Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity. Proc Natl Acad Sci U S A (2008) 2.07

The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J (2004) 2.04

Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci (2005) 1.92

Cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma: a new cause of uveitis. J Immunother (2004) 1.77

Noncanonical autophagy promotes the visual cycle. Cell (2013) 1.74

Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype. J Immunol (2007) 1.65

Immunopathological aspects of age-related macular degeneration. Semin Immunopathol (2008) 1.63

Macrophage polarization in the maculae of age-related macular degeneration: a pilot study. Pathol Int (2011) 1.62

Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol (2009) 1.57

The role of infectious agents in the etiology of ocular adnexal neoplasia. Surv Ophthalmol (2008) 1.57

A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease. Ocul Immunol Inflamm (2007) 1.53

Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition. Proc Natl Acad Sci U S A (2006) 1.52

Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity. J Immunol (2005) 1.50

Vitreous cytokine levels. Ophthalmology (2003) 1.48

Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. J Transl Med (2011) 1.47

An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms. J Exp Med (2003) 1.44

Resolution of autoimmune polyglandular syndrome-associated keratopathy with keratolimbal stem cell transplantation: case report and historical literature review. Cornea (2007) 1.42

Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A. Blood (2011) 1.41

Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD). Prog Retin Eye Res (2010) 1.39

Pathological findings in eyes with the ganciclovir implant. Ophthalmology (2005) 1.38

Ccl2/Cx3cr1-deficient mice: an animal model for age-related macular degeneration. Ophthalmic Res (2008) 1.36

Both Th1 and Th17 are immunopathogenic but differ in other key biological activities. J Immunol (2008) 1.36

Endogenous IRBP can be dispensable for generation of natural CD4+CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity. J Exp Med (2006) 1.34

Choroideremia: new findings from ocular pathology and review of recent literature. Surv Ophthalmol (2009) 1.34

Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation. J Immunol (2002) 1.33

A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice. J Clin Invest (2003) 1.32

Biopsy techniques and yields in diagnosing primary intraocular lymphoma. Int Ophthalmol (2007) 1.31

Aging is not a disease: distinguishing age-related macular degeneration from aging. Prog Retin Eye Res (2013) 1.29

Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. Cell Rep (2012) 1.28

Encapsulated cell-based intraocular delivery of ciliary neurotrophic factor in normal rabbit: dose-dependent effects on ERG and retinal histology. Invest Ophthalmol Vis Sci (2004) 1.27

Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses. J Immunol (2008) 1.26

Waldenström's macroglobulinemia-associated retinopathy. Ophthalmology (2004) 1.26

Sympathetic ophthalmia: to the twenty-first century and beyond. J Ophthalmic Inflamm Infect (2013) 1.25

Ophthalmic manifestations, cytology, immunohistochemistry, and molecular analysis of intraocular metastatic T-cell lymphoma: report of a case and review of the literature. Surv Ophthalmol (2008) 1.24

Ophthalmic manifestations and histopathology of xeroderma pigmentosum: two clinicopathological cases and a review of the literature. Surv Ophthalmol (2011) 1.23

Immunological protein expression profile in Ccl2/Cx3cr1 deficient mice with lesions similar to age-related macular degeneration. Exp Eye Res (2008) 1.19

The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples. Invest Ophthalmol Vis Sci (2007) 1.17

Differential requirement for the ATPase domain of the Cockayne syndrome group B gene in the processing of UV-induced DNA damage and 8-oxoguanine lesions in human cells. Nucleic Acids Res (2002) 1.16

Human HtrA1 in the archived eyes with age-related macular degeneration. Trans Am Ophthalmol Soc (2007) 1.15

Genetic markers and biomarkers for age-related macular degeneration. Expert Rev Ophthalmol (2007) 1.15

Primary intraocular lymphoma. Arch Pathol Lab Med (2009) 1.13

Histopathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levels. Ophthalmology (2003) 1.11

Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice. Invest Ophthalmol Vis Sci (2008) 1.09

Induction of ocular inflammation by T-helper lymphocytes type 2. Invest Ophthalmol Vis Sci (2002) 1.09

Autoreactive memory CD4+ T lymphocytes that mediate chronic uveitis reside in the bone marrow through STAT3-dependent mechanisms. J Immunol (2011) 1.09

A unique pattern of up- and down-regulation of chemokine receptor CXCR3 on inflammation-inducing Th1 cells. Eur J Immunol (2004) 1.08

Diagnosis and management of primary intraocular lymphoma. Hematol Oncol Clin North Am (2005) 1.08

MCP-1 expression in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci (2002) 1.08

Differences in scrapie-induced pathology of the retina and brain in transgenic mice that express hamster prion protein in neurons, astrocytes, or multiple cell types. Am J Pathol (2004) 1.07

Mutations in KCNJ13 cause autosomal-dominant snowflake vitreoretinal degeneration. Am J Hum Genet (2008) 1.07

Breakdown of immune privilege and spontaneous autoimmunity in mice expressing a transgenic T cell receptor specific for a retinal autoantigen. J Autoimmun (2013) 1.07

The HtrA1 promoter polymorphism, smoking, and age-related macular degeneration in multiple case-control samples. Ophthalmology (2008) 1.07

Prolonged analgesic response of cornea to topical resiniferatoxin, a potent TRPV1 agonist. Pain (2010) 1.06

Phenotypic consequences of mutations in the conserved motifs of the putative helicase domain of the human Cockayne syndrome group B gene. Gene (2002) 1.06

Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-gamma deficiency. Invest Ophthalmol Vis Sci (2007) 1.06

A high omega-3 fatty acid diet reduces retinal lesions in a murine model of macular degeneration. Am J Pathol (2009) 1.05

Fluorescein angiographic findings in primary intraocular lymphoma. Retina (2002) 1.05

Differential diagnosis of anterior chamber cysts with ultrasound biomicroscopy: ciliary body medulloepithelioma. Acta Ophthalmol Scand (2006) 1.05

Suppressor of cytokine signaling-1 (SOCS1) inhibits lymphocyte recruitment into the retina and protects SOCS1 transgenic rats and mice from ocular inflammation. Invest Ophthalmol Vis Sci (2011) 1.05

Anti-inflammatory recombinant TSG-6 stabilizes the progression of focal retinal degeneration in a murine model. J Neuroinflammation (2012) 1.04

Genetics of immunological and inflammatory components in age-related macular degeneration. Ocul Immunol Inflamm (2012) 1.04

Retarded developmental expression and patterning of retinal cone opsins in hypothyroid mice. Endocrinology (2008) 1.03

Use of optical coherence tomography and electroretinography to evaluate retinal pathology in a mouse model of autoimmune uveitis. PLoS One (2013) 1.01

Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism. J Clin Invest (2011) 0.99

The effects of quercetin in cultured human RPE cells under oxidative stress and in Ccl2/Cx3cr1 double deficient mice. Exp Eye Res (2010) 0.99

X-linked anhidrotic ectodermal dysplasia disruption yields a mouse model for ocular surface disease and resultant blindness. Am J Pathol (2005) 0.99

Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells. J Immunol (2007) 0.99

Human T-cell lymphotropic virus type-1 associated t-cell leukemia/lymphoma masquerading as necrotizing retinal vasculitis. Ophthalmology (2002) 0.99

Pertussis toxin is superior to TLR ligands in enhancing pathogenic autoimmunity, targeted at a neo-self antigen, by triggering robust expansion of Th1 cells and their cytokine production. J Immunol (2006) 0.98

Effects of flickering light on refraction and changes in eye axial length of C57BL/6 mice. Ophthalmic Res (2011) 0.97

Mouse models of experimental autoimmune uveitis. Ophthalmic Res (2008) 0.97

Role of DAF in protecting against T-cell autoreactivity that leads to experimental autoimmune uveitis. Invest Ophthalmol Vis Sci (2009) 0.97

Exacerbation of retinal degeneration and choroidal neovascularization induced by subretinal injection of Matrigel in CCL2/MCP-1-deficient mice. Ophthalmic Res (2005) 0.96

Association of antiretinal antibodies in acute annular outer retinopathy. Arch Ophthalmol (2008) 0.96

The LOC387715 polymorphism, inflammatory markers, smoking, and age-related macular degeneration. A population-based case-control study. Ophthalmology (2007) 0.96

LX211 (voclosporin) suppresses experimental uveitis and inhibits human T cells. Invest Ophthalmol Vis Sci (2008) 0.96

Disruption of CD40/CD40-ligand interactions in a retinal autoimmunity model results in protection without tolerance. J Immunol (2005) 0.96

A progressive anterior fibrosis syndrome in patients with postsurgical congenital aniridia. Am J Ophthalmol (2005) 0.96